Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: capecitabine|DRUG: bevacizumab|DRUG: capecitabine|DRUG: bevacizumab|DRUG: vinorelbine
Sponsor: iOMEDICO AG
Collaborators: Arbeitsgemeinschaft fur Internistische Onkologie|Arbeitskreis Klinische Studien|Roche Pharma AG